What is David Shin's NPI number?

David Shin's National Provider Identifier (NPI) is 1558320994, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is David Shin's specialty?

David Shin is listed in the NPPES registry with a primary specialty of Urology Physician (Allopathic & Osteopathic Physicians).

Where is David Shin located?

David Shin's practice location on file with NPPES is 360 Essex St, Hackensack, NJ 07601-8550.

What is David Shin's phone number?

The practice phone number listed in the NPPES registry for David Shin is (551) 996-8090.

Does David Shin accept Medicare?

David Shin is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is David Shin's NPI active?

Yes — David Shin's NPI (1558320994) is active in the NPPES registry as of the last update on 2014-12-10.

IndividualActiveAccepts Medicare

David Shin, MD

NPI 1558320994 · Urology Physician · Hackensack, NJ

David Shin, MD is a Urology Physician provider in Hackensack, NJ (NPI 1558320994).

Provider details

NPI number: 1558320994
Entity type: Individual
Primary specialty: Urology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Male
Sole proprietor: No
License: 25MA07773400 (NJ)

Practice location

360 Essex St

Suite 403

Hackensack, NJ 07601-8550

Phone: (551) 996-8090

Fax: (551) 996-8221

Street-level locationGet directions

More NJ providers

Mailing address

360 Essex St

Hackensack, NJ 07601-8550

Specialties & taxonomies

Urology PhysicianPrimary208800000XLicense 25MA07773400 (NJ)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(73/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
879 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	242	$145
Ultrasound Measurement of Bladder Capacity After Voiding51798	151	$14
Urinalysis, Manual Test81002	126	$3
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	94	$19
Insertion of Needle Into Vein for Collection of Blood Sample36415	80	$9
Injection Procedure to Cause Erection54235

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 20 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Tamsulosin Hcl	148	40
Finasteride	61	20
Testosterone	52	—
Alfuzosin Hclbrand: Alfuzosin Hcl Er	36	11
Testosterone Cypionate	36	—
Solifenacin Succinate	28	—
Dutasteride	26

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$587 across 11 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-03-23
Last updated: 2014-12-10

Frequently asked questions

What is David Shin's NPI number?: David Shin's National Provider Identifier (NPI) is 1558320994, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is David Shin's specialty?: David Shin is listed in the NPPES registry with a primary specialty of Urology Physician (Allopathic & Osteopathic Physicians).
Where is David Shin located?: David Shin's practice location on file with NPPES is 360 Essex St, Hackensack, NJ 07601-8550.
What is David Shin's phone number?: The practice phone number listed in the NPPES registry for David Shin is (551) 996-8090.
Does David Shin accept Medicare?: David Shin is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is David Shin's NPI active?: Yes — David Shin's NPI (1558320994) is active in the NPPES registry as of the last update on 2014-12-10.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	242	$145
Ultrasound Measurement of Bladder Capacity After Voiding51798	151	$14
Urinalysis, Manual Test81002	126	$3
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	94	$19
Insertion of Needle Into Vein for Collection of Blood Sample36415	80	$9
Injection Procedure to Cause Erection54235

Drug

Part D claims (2024)

Beneficiaries

Tamsulosin Hcl

148

Finasteride

Testosterone

—

Alfuzosin Hclbrand: Alfuzosin Hcl Er

Testosterone Cypionate

—

Solifenacin Succinate

—

Dutasteride

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$587 across 11 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments